Samphire Neuroscience provides neurotechnology solutions that specialize in women's health.
Samphire Neuroscience has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Samphire Neuroscience's investors include Inventure, SOSV, APEX Capital, Fortify Ventures, Seaside Ventures.
Samphire Neuroscience is headquartered in London, United Kingdom.
Samphire Neuroscience provides neurotechnology solutions that specialize in women's health.
Samphire Neuroscience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Samphire Neuroscience — Funding & Investors." VCBacked, June 3, 2025, https://www.vcbacked.co/company/samphire-neuroscience. Accessed July 19, 2026.
VCBacked. (2025). Samphire Neuroscience — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/samphire-neuroscience
{{cite web |title=Samphire Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/samphire-neuroscience |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated